NEW YORK (GenomeWeb) – Thermo Fisher Scientific today reported a 1 percent year-over-year decline in revenues for the third quarter but still beat the average Wall Street estimate on the top and bottom lines. 

For the three months ended Sept. 26, the company reported total revenues of $4.12 billion, down from $4.17 billion in the year-ago quarter but still above the analysts' average estimate of $4.10 billion. 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The New York Times and ProPublica look into the close relationship between a startup and Memorial Sloan Kettering Cancer Center.

Yahoo News reports millions of dollars are being transferred from NIH, CDC, and other programs to pay for the housing of detained undocumented immigrant children.

In Science this week: in vitro generation of human reproductive cells, and more.

Researchers gave a handful of octopuses MDMA to find that they too act more social on the drug, Gizmodo reports.